[Two cases of intravascular lymphomatosis diagnosed antemortem by transbronchial lung biopsy]

Y Taura1, H Yamazaki, T Katou

  • 1Department of Internal Medicine, Kokura Memorial Hospital.

Insights

Transbronchial lung biopsy enabled early diagnosis of intravascular lymphomatosis (IVL), a rare condition. Chemotherapy achieved remission in one patient, highlighting potential for antemortem treatment of IVL.

Area of Science:

  • Hematology
  • Pulmonology
  • Oncology

Background:

  • Intravascular lymphomatosis (IVL) is a rare hematologic malignancy characterized by proliferation of lymphoid cells within small blood vessels.
  • Diagnosis is often challenging and typically made post-mortem, complicating timely therapeutic intervention.

Observation:

  • Two male patients, aged 71 and 65, presented with high-grade fever, hypoxemia, and elevated lactate dehydrogenase (LDH).
  • Chest CT imaging revealed distinct patterns, including peripheral clear and central high-density areas in one patient, and diffuse mild densities in the upper lungs of the other.
  • Transbronchial lung biopsy (TBLB) was crucial in confirming the diagnosis of IVL in both cases, despite initial suspicion of interstitial pneumonia.

Findings:

  • TBLB provided definitive histopathological evidence of IVL, enabling an antemortem diagnosis in both patients.
  • Patient 1, despite diagnosis, succumbed to the disease before completing chemotherapy.
  • Patient 2 achieved complete clinical remission following CHOP multiagent chemotherapy, demonstrating treatment efficacy.

Implications:

  • This case series underscores the diagnostic utility of TBLB for IVL, facilitating earlier detection than traditional autopsy findings.
  • The successful treatment of Patient 2 suggests that multiagent chemotherapy, such as CHOP, can induce remission in IVL.
  • Early diagnosis and prompt treatment initiation are critical for improving outcomes in patients with intravascular lymphomatosis.

Related Concept Videos